Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/14/22 18:10 | 4/8/22 | FMTX | Health | BioPrd | Biological Products, (No Diag | Kelly Patrick F. | MA | O | SVP,Chie | M.d | 76 | 5.05 | 0 | 15 | 17 | 105 | D | ||||||||||||||
2/25/22 17:08 | 2/23/22 | FMTX | Health | BioPrd | Biological Products, (No Diag | Lee Frank D. | MA | DO | P,CEO | S | -176 | 9.78 | 0 | -18 | -18 | 80 | D | ||||||||||||||
2/25/22 17:08 | 2/23/22 | FMTX | Health | BioPrd | Biological Products, (No Diag | Kelly Patrick F. | MA | O | SVP,Chie | S | -51 | 9.78 | 0 | -5 | -7 | 65 | D | ||||||||||||||
2/25/22 17:04 | 2/23/22 | FMTX | Health | BioPrd | Biological Products, (No Diag | Shegog Todd | MA | O | SVP,CFO | S | -56 | 9.78 | 0 | -6 | -20 | 23 | D | ||||||||||||||
2/25/22 17:01 | 2/23/22 | FMTX | Health | BioPrd | Biological Products, (No Diag | Potts Jeannette | MA | O | See Rema | S | -46 | 9.78 | 0 | -5 | -17 | 22 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |